The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock
Vasopressors and inotropes (Vs/Is) are widely used in the treatment of cardiogenic shock (CS). Despite improvements in hemodynamic variables and end-organ perfusion, these agents have been associated with an increase in mortality, potentially due to the increased risk of tachyarrhythmias—which we hy...
Main Authors: | Rachel Ryu, Christopher Hauschild, Khaled Bahjri, Huyentran Tran |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Medical Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3271/10/4/64 |
Similar Items
-
State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock
by: Jason E. Bloom, et al.
Published: (2023-08-01) -
Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database
by: Bryan Richard Sasmita, et al.
Published: (2023-11-01) -
Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis
by: Mina Karami, et al.
Published: (2020-06-01) -
Vasopressors in Septic Shock
by: Vinay H Joshi, et al.
Published: (2018-01-01) -
Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial
by: Pietro Di Santo, et al.
Published: (2021-08-01)